PFE lost a lot of revenue (compared to 1Q17) to patent expirations, e.g. Lyrica. This was known beforehand, so it shouldn't be a "show stopper" for anybody.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”